Filter
2352
Filtered Results: 2352
Text search:
US
Agency
for
International
Development,
Centers
for
Disease
Control
and
Prevention
Featured
Recommendations
203
New Publications
700
Language
Document type
No document type
1437
Studies & Reports
427
Guidelines
202
Manuals
125
Strategic & Response Plan
86
Training Material
35
Situation Updates
16
Fact sheets
11
Infographics
6
Resource Platforms
5
Online Courses
1
Videos
1
Countries / Regions
Global
101
Kenya
71
Liberia
70
Nigeria
58
Ethiopia
56
Sierra Leone
54
India
53
Western and Central Europe
53
Uganda
52
Nepal
48
Malawi
48
Zambia
41
Rwanda
38
Syria
37
Ukraine
33
Tanzania
32
Africa
32
Ghana
31
Bangladesh
30
South Africa
29
Latin America and the Carribbean
29
Myanmar / Burma
28
Namibia
27
Philippines
26
Guinea
25
Cambodia
25
Congo, Democratic Republic of
23
Senegal
19
South Sudan
19
Asia
19
Eastern Europe
19
Zimbabwe
17
Haiti
17
Indonesia
16
Mozambique
16
Lesotho
16
South–East Asia Region
14
Eswatini/ Swaziland
11
Botswana
11
Yemen
10
East and Southern Africa
10
USA
9
Somalia
9
Burkina Faso
8
Pakistan
8
Brazil
8
Russia
8
Thailand
7
Venezuela
7
Jordan
6
Afghanistan
6
West and Central Africa
6
Laos
6
Germany
5
Central African Republic
5
Colombia
5
Eastern Europe and Central Asia
5
Palestine
5
Cameroon
4
Papua New Guinea
4
Sudan
4
Benin
4
Peru
4
Sri Lanka
4
Middle East and North Africa
4
Vietnam
4
Mali
3
Iraq
3
Burundi
3
El Salvador
3
Bolivia
3
Angola
3
Madagascar
3
Western Pacific Region
3
Albania
3
Armenia
3
Tajikistan
3
Moldova
3
Georgia
3
Côte d’Ivoire / Ivory Coast
2
Niger
2
Chad
2
China
2
Argentina
2
North Macedonia
2
Hungary
2
Honduras
2
Mexico
2
Chile
2
Poland
2
Canada
2
Timor Leste/ East Timor
2
Bulgaria
2
Romania
2
Slovakia
2
Jamaica
2
Guinea-Bissau
1
Lebanon
1
Turkey
1
Egypt
1
Gambia
1
Malaysia
1
Mauritania
1
Ireland
1
Ecuador
1
Libya
1
Other region
1
Paraguay
1
Fiji
1
Bhutan
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Belgium
1
Mauritius
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
904
Clinical Guidelines
151
Public Health
135
Key Resources
118
Women & Child Health
114
Capacity Building
37
Pharmacy & Technologies
35
Toolboxes
HIV
193
TB
167
COVID-19
151
Mental Health
146
Planetary Health
100
Ebola
89
Conflict
79
Rapid Response
75
AMR
75
Caregiver
53
Disability
51
Global Health Education
49
Pharmacy
49
NTDs
37
Refugee
34
Natural Hazards
33
Health Financing Toolbox
33
NCDs
28
Specific Hazards
22
Zika
17
Polio
15
Cholera
12
Social Ethics
3
South Sudan
2
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first re...
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
As information about COVID-19 is rapidly evolving, it can be challenging to navigate and synthesize all of the information. The purpose of this document is to provide a synthesized, indexed reference of accurate, standardized COVID-19 information fr...
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities ... limitations in the capacities of countries at all levels of development to prevent major health crises or respond to them. But it doesn’t have to be this way.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested.
Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory ... and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs are equivalent to 3.6% of gross domestic product. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment.
This guidance note is meant to assist humanitarian actors, youth-led organizations, and young people themselves across sectors, working at local, country, regional, and global levels in their respon...
To support countries in adapting their response to different COVID-19 scenarios, the World Health
Organization (WHO) Department of Maternal, Newborn, Child and Adolescent Health and Ageing commissi...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unif...
"This document has been developed for outpatient oncology
facilities to serve as a model for a basic infection
control ... prevention plan. It contains policies
and procedures tailored to these settings to meet minimal
expectations of patient protections as described
in the CDC Guide to Infection Prevention in Outpatient
Settings."
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of re...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases ... disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate programmatic action (pillar 1), intensify cross-cutting approaches (pillar 2) and change operating models and culture to facilitate country ownership (pillar 3).
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps ... strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed structure of the NSP. The target audience of this publication are all stakeholders involved in national strategic planning for TB (e.g., ministry of health, other government ministries, private sector, civil society, affected communities, academic and research institutions, and technical and funding partners).
The current document is an update to the 2015 Toolkit to develop a national strategic plan for TB prevention, care and control.
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half ...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate ... analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting and suggest improvements. Methods: Data were collected via a literature review and analysis of financial reporting databases, including both amounts donated and received. Funding information from three financial databases was analysed: Institute of Health Metrics and Evaluation’s Development Assistance for Health database, the Georgetown Infectious Disease Atlas and the United Nations Financial Tracking Service. A systematic literature search strategy was devised and applied to seven databases: MEDLINE, EMBASE, HMIC, Global Health, Scopus, Web of Science and EconLit. Funding information was extracted from articles meeting the eligibility criteria and measures were taken to avoid double counting. Funding was collated, then amounts and purposes were compared within, and between, data sources.
Evidence shows that oral pre-exposure prophylaxis (PrEP) reduces the risk of contracting HIV during sexual intercourse by more than 90% when taken daily. It is for this reason the National HIV Prevention Strategy 2015-2020 (2018 Revision) emphasi...
